SOL Global’s Heavenly Rx to Merge With Therapix Biosciences

SOL Global (CSE: SOL) announced this morning that their 40.7% owned portfolio company Heavenly Rx will be completing a reverse takeover transaction with Nasdaq listed Therapix Biosciences (NASDAQ: TRPX). The two firms signed a memorandum of understanding for the business combination, which will see Heavenly Rx’s CBD operations merge with Therapix and their cannabinoid pharmaceutical assets.

Following the signing of the MOU, Heavenly Rx and Therapix will now work towards signing a definitive agreement. In the interim, the two firms have agreed to a share exchange, with Therapix issuing up to 20% of its shares to acquire an interest in Heavenly Rx. The share exchange agreement is expected to close within thirty days.

The reverse takeover will see Therapix change its name to Heavenly Rx, while remaining listed on the Nasdaq. Current Heavenly CEO Paul Norman will then become the Chief Executive of the public issuer.

Therapix Biosciences may be known by some within the cannabis sector for its previously terminated binding letter of intent with FSD Pharma. Under the agreement, Therapix was to be obtained by FSD as a means for the Canadian cultivator to acquire dual listing on the US big board. FSD Pharma had proposed to modify the terms of the binding letter of intent with terms that Therapix could not agree to, resulting in the Nasdaq listed issuer walking from the transaction.

No date was provided for the expected closing of the arrangement between SOL Global’s Heavenly Rx and Therapix Biosciences.

SOL Global last traded at $0.42 on the CSE.


Information for this briefing was found via Sedar and SOL Global. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Cobb To Become CEO of CannCure, Step Down From SOL Global

SOL Global (CSE: SOL) announced this evening that its investee CannCure will be going public...

Wednesday, January 8, 2020, 05:48:28 PM

SOL Global Investments Announces New Green Investment Firm House Of Lithium

SOL Global Investments Corp. (CSE: SOL) today announced the launch of a specialized investment company...

Monday, September 13, 2021, 10:31:20 AM

Bluma Wellness Expected To Commence Trading June 15

SOL Global Investments (CSE: SOL) portfolio company Bluma Wellness (CSE: BWEL.u) is set to commence...

Sunday, June 14, 2020, 10:43:06 PM

SOL Global’s CannCure to Become Next Public MSO With Operations in Florida, Michigan, and California

SOL Global Investments Corp (CSE: SOL) announced this morning that it would be spinning out...

Monday, June 3, 2019, 01:27:14 PM

SOL Global’s CannCure Secures $15 Million Loan

SOL Global (CSE: SOL) portfolio company CannCure has closed a significant construction loan, totalling out...

Friday, February 21, 2020, 01:53:49 PM